Drugs & medicalClass II

CIPLA recalls Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies Limited., L-32, 33, 34,…

Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Read the official notice →
Date
2022-07-27
Country
United States
Brand
Cipla
Product
Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies Limited., L-32, 33, 34,…
Classification
Class II
Units
Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Cipla recalls

  1. 2024-05-01
  2. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30…

    Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.

    FDA · DrugCipla USA, Inc.USA nationwide.Official notice →
  3. 2023-07-19
  4. US
    Drugs & medicalClass I

    Cipla USA, Inc. recalls Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured…

    Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).

    FDA · DrugCipla USA, Inc.Nationwide in the USOfficial notice →
  5. 2022-10-12
  6. US
    Drugs & medicalClass II

    CIPLA recalls Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 x 2 mL Sterile Unit-Dose Vials per pouch,…

    Lack of Assurance of Sterility: environmental monitoring failure.

    FDA · DrugCIPLAProduct was distributed nationwide to distributors/wholesalers who may have…Official notice →
  7. 2022-10-05
  8. US
  9. 2022-09-14
  10. US
    Drugs & medicalClass II

    CIPLA recalls Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured for Exelan Pharmecuticals, Inc., Boca Raton, FL 33432, NDC…

    Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

    FDA · DrugCIPLANationwide in the USAOfficial notice →
  11. 2022-08-17
  12. US
    Drugs & medicalClass II

    CIPLA recalls Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured…

    Lack of Assurance of Sterility: Complaints received of defective container closure.

    FDA · DrugCIPLANationwide in the USAOfficial notice →
All 20 Cipla recalls →

Other drugs & medical recalls in the United States

  1. 2022-07-27
  2. US
    Drugs & medicalClass I

    Loud Muscle Science recalls Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

    Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

    FDA · DrugLoud Muscle ScienceThe product was distributed nationwide in the USA and Canada.Official notice →
  3. US
    Drugs & medicalClass I

    Amazon.com, Inc. recalls Artri Ajo King Reforzado con Ortiga y Omega 3 tablets, 500 mg, 100-count bottle, Hecho en Mexico por: PLANTAS MEDICINALES DE MEXICO ,…

    Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.

    FDA · DrugAmazon.com, Inc.Nationwide within the U.S.A.Official notice →
  4. US
    Drugs & medicalClass II

    Apotex Corp. recalls Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC…

    Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.

    FDA · DrugApotex Corp.USA NationwideOfficial notice →
  5. US
    Drugs & medicalClass III

    Glenmark Pharmaceuticals Inc., USA recalls Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark…

    Failed Tablet/Capsule Specification : Capsule breakage

    FDA · DrugGlenmark Pharmaceuticals Inc., USAUSA NationwideOfficial notice →
  6. US
  7. US
    Drugs & medicalClass II

    Vi-Jon, LLC recalls Hydrogen Peroxide Topical Solution USP, 3%, 16 FL OZ (1 PT) 473 mL bottle, packaged as a) Signature Care NDC 21130-871-43 UPC 3…

    Cross Contamination With Other Products: Product is cross contaminated with low levels of isopropyl alcohol.

    FDA · DrugVi-Jon, LLCNationwide in the USA and CanadaOfficial notice →
See all drugs & medical recalls →